(CercleFinance.com) – Genomic Vision announces the issue of the fifth and sixth tranches of bonds convertible into shares with BSA (OCABSA) for two million euros, within the framework of the contract of June 11, 2020 with Winance for an amount maximum total of 12 million.
The biotechnology company specifies that these OCs must be subscribed by the investor within ten working days following the decision of the management board, if the usual conditions of the request are met. The net proceeds from the transaction will be € 1.9 million.
Copyright © 2021 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
